Organo Corporation
Cite as: Japan IR Index, Organo Corporation (6368), methodology GNT-BDS v1.1.1, reviewed 2026-10-12.
Findings and sources as of the review date shown. The company’s English disclosure may have changed since.
Where to start
Chosen from this company's lowest answers, easiest first. A quick fix uses material the company already has; a translation fix is usually met by translating a Japanese document (our note says whether this company has one). Questions that need a budget or a board decision are left out. Suggestions drawn from the research, separate from the scores.
O7 Named English IR contact published 3/5 Quick fix
Link a dedicated IR contact (form, address or e-mail) from the English IR section.
S7 Progress against the previous plan, including misses, explained in English 3/5 Translation
Set the previous plan's targets against the results in English, and explain the misses.
O5 Single page listing all English IR documents by date and type 4/5 Quick fix
Keep one English page that lists every IR document with its date and type.
S3 English equity-story or investment-highlights page 4/5 Translation
Put the investment case, with figures, on one English page or section.
English disclosure assessment
All 34 questions reviewed by the editor against the public documents; this is not an independent audit. 1 answer corrected after re-checks (research errors) on 23 Oct 2026. These are changes to our record, not to the company’s disclosure. Changes to this record →
Compared with peers
| Peer group | Median | This company |
|---|---|---|
| Same sector (Machinery) | 76.4 | 9 of 39 |
| Same size band (¥500bn–2tn) | 84.2 | 15 of 43 |
Compared with the companies covered here, not the whole market. Sector is the TSE 33-sector classification; market cap is from the TSE English-disclosure survey, Aug 2026; it only sets the size band, plays no part in the score, and is refreshed once a quarter. Ties share the higher rank.
Out of 100.
Of the 34 questions reviewed, 32 scored 3 or more and 1 found no qualifying English materials within the stated review scope. Read each score with its source and scope below.
Findings by question
F1Quarterly and full-year results summaries (tanshin) published in English5/5
Consolidated Financial Results for the First Three Months of the fiscal year ending March 2027, 3 August 2026, the same day as the Japanese: 13 pages with the qualitative information on results (by segment), the statements and the segment information note, plus English supplementary financial materials. Source document →
F2English results summary is a full translation, not an excerpt5/5
Q1 FY3/2027 (3 Aug 2026): the English 'Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2027' is 13 pages against 12 for the Japanese 2027年3月期 第1四半期決算短信. It has the summary pages, then 1. qualitative information (operating results with a narrative for each segment, financial position, forecast explanation including the revised orders forecast), and 2. the balance sheet, income and comprehensive income statements and the notes (going concern, shareholders' equity, specific tax accounting, additional information on the share split, cash-flow note, segment information). The FY3/2026 year-end tanshin (13 May 2026) is 26 English pages against 24 Japanese, with the overview, future outlook, accounting-standards policy, all four statements and the notes (scope of consolidation, segments, per-share, subsequent events), plus the non-consolidated summary. The whole tanshin, so 5. Source document →
F3Financial statements including notes available in English5/5
The latest-period English tanshin (Q1 FY3/2027, 3 Aug 2026) carries the quarterly consolidated balance sheet, income statement and comprehensive income statement with the notes (going concern, equity changes, tax accounting, share split, depreciation in place of a cash-flow statement, which the Japanese Q1 also omits, and the segment note). The year-end English tanshin (13 May 2026) adds the statements of changes in equity and cash flows and the full notes. Full statements and notes for the latest period, so 5. Source document →
F4Annual securities report available in English in any form0/5
The English IR library's sections are financial results, IR presentation materials, timely disclosure and the Organo Group Report. No securities report in English under any name.
F5Segment revenue and profit disclosed in English, consistent definitions5/5
Two reportable segments: Water Treatment Engineering and Performance Products. Every English tanshin's segment note gives external and intersegment sales and segment profit for each, reconciled to operating profit (Q1 FY3/2027: Water Treatment Engineering sales ¥34,923m, profit ¥5,702m; Performance Products ¥7,259m and ¥910m). The year-end tanshin's note states the segment definitions, listing the divisions and major products of each (Plant and Service Solutions; Water Treatment Chemicals, Standard Water Equipment and Functional Materials, Food Products) and that segment profit is operating profit. The qualitative section narrates orders, sales and profit by segment each quarter, and the deck adds sales by division and by market. Every period, definitions stated, so 5. Source document →
F6Multi-year financial data file (Excel or CSV) downloadable in English5/5
The English Financial Data page (IR Pocket chart tool) has a 'Download (Excel / PDF)' link to data_en.xlsx (irpocket.com/6368/chart__ver2_hc6/data_en.xlsx), which we opened inside the rendered page. Sheet 'Fiscal Year' covers six years, FY2020 to FY2025 (to the year ended March 2026): operating results (orders, net sales, operating income, net income, margins, ROE, ROA); financial position (total, current and non-current assets, total, current and non-current liabilities, net assets, shareholders' equity, equity ratio, interest-bearing debt, D/E); cash flows (operating, investing, financing, FCF, ending cash); key indicators (capex, R&D, depreciation, employees); and per-share data (EPS, BPS, dividend, payout ratio). Sheet 'Quarterly' has cumulative quarterly orders, sales, operating income and net income from FY2023 Q2 to FY2026 Q1 (the June 2026 quarter); the file was updated 3 Aug 2026. Balance sheet and cash flow are at summary level and there are no segments. Excel with six years of P&L, balance sheet, cash flow and per-share data, so 5. Source document →
F7Guidance disclosed in English with the basis explained5/5
The year-end English tanshin (13 May 2026) gives the FY3/2027 forecast (orders ¥230.0bn, sales ¥200.0bn, OP ¥40.0bn, ordinary ¥40.0bn, net ¥30.0bn, ROE 20.0%) with its basis: Middle East supply and cost risks, and high capex in cutting-edge semiconductors in Japan, Taiwan and the US. The English FY deck (13 May 2026) has an 'Assumptions for FY Ending 03/2027 Plan' page (Middle East impact, semiconductor market conditions, sales portfolio), first-half and full-year plans, and a plan by segment (orders, sales and profit for Water Treatment Engineering and Performance Products). It also sets actuals against the initial plan and the 31 Oct 2025 revised forecast with explanations. The Q1 tanshin (3 Aug 2026) explains the upward revision of the orders forecast (H1 ¥170.0bn, full year ¥300.0bn) and that sales and profit are unchanged. No FX assumption is given, but market view and segment forecasts plus explained revisions meet the two-of-three test, so 5. Source document →
F8English financial disclosure current to the latest Japanese filing period5/5
English results for the quarter ended 30 June 2026 published 3 August 2026, the same period and day as the Japanese filing. Source document →
S1Medium-term management plan in English with numerical targets5/5
The current plan is the Medium- to Long-term Management Plan 'ORGANO 2030', whose targets were revised again in May 2026. FY ending 03/2031: net sales ¥260.0bn or more (base CAGR 7%+), OP ratio 18-20%, ROE 20%+, ROIC 15%+. They are set out in the English FY3/2026 deck (13 May 2026, the same day as the Japanese; 40 pages both sides). The deck covers plan overview, risks and opportunities, growth drivers, the plan by department and market with CAGRs to 03/2031, and a capital allocation plan for FY3/2027-FY3/2029 with ranges. The English Management Strategy page repeats the targets. Current, as complete as the Japanese, so 5. Source document →
S2IR presentations published in English5/5
For each results briefing (full year and half year) the English side gets the presentation and a summary of the Q&A (full year FY2025: deck 13 May 2026, Q&A 22 May), and for Q1 and Q3 the same supplementary financial materials as the Japanese. The Japanese library's grid shows nothing more. Source document →
S3English equity-story or investment-highlights page4/5
The English 'For Individual Investors' page has a dedicated investor-framed section, 'Get to Know Organo in Three Minutes'. It answers what the company does, its strengths (partner model combining water-treatment technology with operation and management services), where it operates, growth and shareholder returns, then 'Our Vision for 2030' by field. It is specific but mostly qualitative, with no quantified strengths on the page. The Organo Group Report has 'Organo's Three Strengths' (p.7) and the Discover Organo / Our Strengths pages describe technology. Dedicated, mostly qualitative, so 4. Source document →
S4Growth drivers identified and quantified in English5/5
The English FY deck (13 May 2026) names the drivers and quantifies them. Core, growth and emerging drivers are cutting-edge semiconductors in Taiwan and the US, Field Solutions and Performance Products, and new businesses and regions. There are sales and CAGR charts by market, business and region to 03/2031, the plant share of electronics sales (36% of FY3/2026 sales, possibly above 50% from FY3/2028), US orders 'in the tens of billions of yen', and facility-owned services investment (¥22.9bn reclassified in FY3/2026, ¥8.0bn planned). The Organo Group Report 2025 (p.11) adds a semiconductor market forecast to 2035 and the target split, electronics ¥160.0bn (+8.8% CAGR) against other ¥90.0bn (+5.1%). Named drivers with numbers, so 5. Source document →
S5Results-briefing transcripts or Q&A published in English4/5
Q&A summaries are published for each briefing on both sides (full year and first half). FY3/2026 briefing: Japanese 決算説明会 質疑応答要旨 posted 15 May 2026 (3 pp); the English 'Summary of Q&A on Financial Results Presentation Meeting for the Fiscal Year Ended March 31, 2026' posted 22 May 2026 (4 pp), 7 days later. H1 FY3/2026: Japanese 5 Nov 2025; English 14 Nov 2025 (4 pp), 9 days later. Earlier years follow the same pattern (FY3/2025: English 6 Jun 2025). Every briefing covered, but days after the Japanese, so 4. Source document →
S6Integrated or annual report available in English4/5
Organo Group Report 2025 in English, 40 pages (January 2026), looking back on FY2024 (the year ended March 2025). Complete, one edition behind the year since closed. Source document →
S7Progress against the previous plan, including misses, explained in English3/5
ORGANO 2030 is a ten-year plan set in 2020 and revised rather than replaced. The English Organo Group Report 2025 sets the initial targets (sales ¥200.0bn, OP ¥30.0bn, OP ratio 15%, ROE 12%+) beside the revised ones. The President's message says the FY2030 OP target of ¥30.0bn was reached in FY2024, ahead of schedule. The English FY3/2026 deck (p.14) shows the initial OP-ratio range 15-18% being raised to 18-20% 'in light of current levels'. Progress is narrated with some numbers, but there is no table of each target against actuals with variances explained, so 3. Source document →
G1Corporate governance report available in English5/5
The Corporate Governance Report in English, 'Last updated June 29, 2026', on the English governance page beside the Corporate Governance Guidelines - current. Source document →
G2Director biographies in English with tenure, expertise and independence5/5
The English notice of the 81st AGM (98 pp, posted 5 Jun 2026) covers the election of nine directors, the whole board. For each candidate it gives 'Tenure as Director' in years, a dated career summary, significant concurrent positions, shares held and reasons for nomination. It names the five outside directors and says they are designated independent officers under TSE rules, with the criteria for independence. The audit-board candidates get the same treatment. The English Board Composition page adds reasons for appointing each outside director. Every director, with tenure, career and independence, so 5. Source document →
G3Board skills matrix published in English5/5
The English 'Board Composition and Remuneration' page has the current Director Skills Matrix for the nine directors elected in June 2026, outside directors marked. It covers eight skills: management and strategy, finance and accounting, legal and risk, global, sales and marketing, technology, HR strategy and sustainability. Each skill has a definition and selection rationale tied to ORGANO 2030. The English AGM notice (p.26) carries the planned post-AGM matrix too. Current matrix in English, so 5. Source document →
G4Executive remuneration structure and its performance linkage explained in English5/5
The English AGM notice's business report section '(5) Remuneration, etc. for Directors and Audit and Supervisory Board Members' (pp.46-48) sets out the structure. Executive directors receive fixed pay plus performance-linked pay, about 50-60% of the total at standard, split roughly 8:2 between short-term cash and medium- to long-term shares. The KPIs: consolidated operating profit drives the cash bonus (0-140%) and consolidated ROE the trust-based share award (0-200%, three-year transfer restriction). Non-executives get fixed pay only. The shareholder-approved limits are given, and FY3/2026 amounts by type: directors excluding outside, ¥226m total, of which fixed ¥84m, short-term ¥94m and share-based ¥48m, for four people. Structure, KPIs, weights and amounts by pay type, so 5. Source document →
G5AGM notice in English with sufficient lead time to vote4/5
Notice of the 81st Ordinary General Meeting, posted in English on 5 June 2026 for a meeting on 26 June - 21 days - 98 pages with the reference documents. The Japanese-only label attaches to the s.srdb.jp posting site, not to the voting route. Re-checked 23 Oct 2026 (G5 voting-site sweep, after the independent audit): the English notice itself labels the voting website 'www.web54.net (in Japanese)' (Sumitomo Mitsui Trust Bank), and it is in Japanese only, with no English option, as for ESPEC (6859) and Nitto Boseki (3110). Every proposal in English, but a Japanese-only voting route, so 4. Source document →
G6Shareholder vote results disclosed in English5/5
The Extraordinary Report on the 81st AGM (filed 30 June 2026) is on the English General Meeting page: the numbers of voting rights for approval, disapproval and abstention, the approval requirement and the result for each resolution. Source document →
G7Cross-shareholdings in English with reduction schedule and rationale3/5
The English Corporate Governance Report (last updated 29 Jun 2026), Principle 1.4, gives the policy: holdings only where they raise corporate value. The board reviews each holding yearly on stated criteria, including no or insignificant transactions over three years. The June 2026 review covered all 11 issues and decided to sell one listed holding, with some previously flagged holdings being 'gradually' reduced. At 31 Mar 2026 the total was ¥833m, under 1% of total assets. Voting criteria are given. There is no reduction target or schedule. Policy, numbers and the board's rationale, but no target, so 3. Source document →
O1English IR section reachable within two clicks of the English homepage5/5
The English homepage (organo.co.jp/en/) has a visible 'Investors' link in its 'Company Information / Investor Relations' block that goes straight to the IR top (/en/ir/). The 'Investor Relations' item in the main navigation opens a menu whose first entry is 'Investor Relations Top'. One click from the homepage, so 5. Source document →
O2English document links resolve to English documents5/5
We opened 21 English document links across types, all in English. Tanshin: Q1 FY3/2027 (nbqv and ZaB7), FY3/2026 (yk5c), FY3/2022 (NqtE). Q1 supplementary (r7cl). Decks: FY3/2026 (ddFM), H1 FY3/2026 (oqVI), the 2013 briefing (LzkA). Q&A: FY (Jt0z) and H1 (mauo). AGM notice (ynpN), extraordinary report (eOKU), CG report (microcms). Timely disclosures: w4QN, PQK5, lVp4, zcWb. Organo Group Report 2025 (j2nn) and its section file (cU8T), Group Report 2020 (WX8L). Articles of Incorporation. None was Japanese, so 5. Source document →
O3English IR archive free of dead links5/5
All 21 documents in the O2 sample opened in the rendered browser, from 2013 to Aug 2026, across the Financial Results, Presentation, Timely Disclosure, Integrated Report, AGM, governance and Articles pages. No dead links, so 5. Source document →
O4English IR pages render without blank JavaScript failures5/5
In the rendered browser, the main English IR pages all rendered their content. These were the IR top (latest materials, calendar), IR Library grid, Financial Results, IR Presentation Materials, Timely Disclosure, Organo Group Report, the Financial Data chart tool (charts and tables), Stock Price Information (live quote and chart), General Meeting, Shareholder Returns and For Individual Investors. No blank lists or widgets. One cosmetic slip: the IR top banner labels the Aug 2026 Q1 as 'Fiscal Year Ended March 2026'. Every page renders, so 5. Source document →
O5Single page listing all English IR documents by date and type4/5
The English 'IR Library' page is one grid by period with year tabs back to FY2013. Each fiscal year's columns (Q1, Q2, Q3, full year) carry typed rows: video, Financial Results, Supplementary Financial Materials, Presentation Materials, Q&A. Timely disclosures, the Organo Group Report and AGM/governance documents sit on separate typed pages, each listed by date with year filters. The English IR news list is a single dated list of IR postings, but untyped. One page dated and typed by period, missing some types, so 4. Source document →
O6English archive genuinely populated, not an unverifiable shell5/5
The English archive is populated across types and years. Tanshin every quarter from FY3/2020 (May 2019 onward, with 'Show historical data'). Results decks and Q&A summaries from FY2013 to 2026. Timely disclosures from May 2022 (FY2021). Organo Group Reports 2020-2025, AGM pages with past meetings, and a six-year Excel data file. Several years across document types, so 5. Source document →
O7Named English IR contact published3/5
Named in the tanshin header - Minoru Ando, General Manager of Accounting Dept. The IR menu's 'Contact Us' item leads to the general contact page, whose corporate form covers 'IR, company information, careers, and other' together. A genuine route, shared, not a dedicated IR contact. Source document →
R1Earnings materials published in English simultaneously with Japanese4/5
Tanshin: English the same day as the Japanese in every period read. Q1 FY3/2027 3 Aug 2026 both (Q1 has no deck on either side). FY3/2026 13 May 2026 both. Q3 4 Feb 2026 both. H1 31 Oct 2025 both. Q1 FY3/2026 4 Aug 2025 both. Decks: FY3/2026 English 13 May 2026, the same day as the Japanese. The H1 FY3/2026 deck came out in Japanese on 4 Nov 2025 and in English on 14 Nov 2025, 10 days later (the English PDF was created 13 Nov). Earlier years lagged more (Q1 FY3/2025 tanshin JP 31 Jul 2024 against EN 7 Aug 2024). The latest two results were simultaneous, but one deck in the last year was 10 days late: tanshin same day, deck later, so 4. Source document →
R2Median lag in days between Japanese and English statutory publication4/5
From the listing dates. Latest two tanshin: Q1 FY3/2027 3 Aug 2026 in both languages (0 days); FY3/2026 13 May 2026 in both (0 days). AGM notice: English on the IR news list 5 Jun 2026; both notices are dated 5 Jun, and the Japanese PDF was last modified 2 Jun 11:27, against 11:31 for the English. The Japanese posting date is not shown on the site (its news list shows only the latest ten), so 0-3 days. CG report: Japanese 'last updated 29 June 2026'; the English PDF, with the same date, was created 7 Jul 2026, about 8 days later (PDF date). Securities report: Japanese 25 Jun 2026, no English (>90). Lags 0, 0, 0-3, ~8, >90: the median is the AGM notice's 0-3 days. Recording the floor, 1-7, so 4. Source document →
R3Timely disclosures published in English4/5
Twelve months of the Japanese 適時開示資料 list (Oct 2025 - Oct 2026) against the English Timely Disclosure page and news list. 31 Oct 2025 interim dividend and year-end forecast revision: English same day. 13 May 2026, all four in English the same day: officer changes, dividends, the share split with Articles amendment, and controlling-shareholder matters. The officer notice is misfiled on the English TD page as 'May 13, 2025', but the PDF is dated 13 May 2026 and the English news list shows it then. The quarterly and year-end tanshin were also same day. One item has no English counterpart: the 12 Nov 2025 correction notice for the H1 FY3/2026 results deck (the corrected English deck was simply posted on 14 Nov). Nearly all, same day, so 4. Source document →
R4English disclosure free of machine-translation accuracy disclaimers5/5
No machine-translation notice on the rendered English pages (homepage, IR top, library pages, governance, individual investors) or in the documents read (tanshin, deck, AGM notice, CG report, Group Report). The English documents carry a human-translation 'Japanese version shall prevail' disclaimer, which is R5's. The Website Terms of Use has only a general accuracy disclaimer. The IR Pocket 'About IR site' note says the data may not be accurate, but says nothing about machine translation. The Disclosure Policy says the company provides information in English 'within a reasonable scope'. Nothing presented as machine-translated, so 5. Source document →
R5English version stated as authoritative, not subordinate to Japanese2/5
The tanshin and the AGM notice carry 'This English version is not an official translation ... the Japanese version shall prevail'. The extraordinary report and the Organo Group Report carry no such statement. Disclaimed on some documents. Source document →
Open a question for the reasoning and the document its score was read from. A zero means no qualifying English materials were located within the stated review scope as of 2026-10-12. Compare this question across companies →
Capital-policy review
Not scored. 1 action has been reviewed; a score out of 100 is published once 3 or more are. The ratings:
Each action is read against the company’s own filings on four checks: was the promise specific, can the steps be traced, were the economics explained, and did it report back against the target. This records the status of selected actions, not an assessment of the company as a whole. How this is scored →
Ultrapure-water growth, portfolio expansion and return plan
Strategy or target reset · In progress · Plan announced 1 June 2026
Organo updated its FY2030 ambitions after achieving the original operating-profit target ahead of schedule.
Timeline and sources (1 step)
- 1 June 2026Plan announced Organo updated its FY2030 ambitions after achieving the original operating-profit target ahead of schedule. Medium- to Long-Term Management Plan ORGANO 2030
What management said it would do
Management targets at least ¥260bn sales, 18% operating margin, 20% ROE and 15% ROIC by FY2030.
From the company’s own disclosure · Medium- to Long-Term Management Plan ORGANO 2030
What it actually did, and when
The original 2030 profit target was achieved early and the plan was reset; the new execution cycle is underway.
Partly disclosed — a gap remains · Medium- to Long-Term Management Plan ORGANO 2030 · Message from the President
What it disclosed about the economics
The plan prioritizes semiconductor water systems, service solutions, functional products, the U.S. and inorganic expansion.
Partly disclosed — a gap remains · Medium- to Long-Term Management Plan ORGANO 2030 · Message from the President
What has happened since
The FY2030 result is not due.
Partly disclosed — a gap remains · Medium- to Long-Term Management Plan ORGANO 2030
The question this leaves open
Investor question: How much incremental capital is needed to sustain the higher targets? IR preparation: disclose regional project capital, service mix and ROIC.
Our analysis, not a company statement
Balance sheet and capital-policy indicators
A source-backed first-pass capital-efficiency, balance-sheet and governance reading, separate from the accountability score.
Cash use and returns
Organo is investing in semiconductor ultrapure-water capacity, service solutions, functional products and new geographies, including inorganic options.
Capital structure
Management aims to balance growth investment with rising dividends, but the selected current sources provide less quantified leverage and liquidity detail.
Governance of capital decisions
The updated plan added ROIC and raised 2030 sales, margin and return targets after achieving the original profit goal early.
Preliminary and not scored: a selected-source reading, reviewed 29 September 2026. Surplus cash, leases, maturities, project ROIC, cost of capital, committed spend and peer comparability are not fully assessed; none enters the accountability score. Figures are the company’s own reported numbers; a large cash balance is not called excess without a defensible operating reserve and investment plan. Every company with a balance-sheet reading →
Changes to this record
- Research error 23 October 2026 · G5: 5 → 4. Every proposal is in the English notice, but the voting website shareholders use (Sumitomo Mitsui Trust Bank) is in Japanese only.
Every change is labelled as a research error, new evidence supplied, improved disclosure or a rule change, with its date and the previous score. Change log →
Scores assess how English information is published, not the quality of the business or its investment value. To report an error or a document we missed, see how to contact us.